Today we are reminded that antibiotics are an important part of treatment regiments not only for severe antiviral infections, such as COVID-19, but also other hospitalized patients with multidrug-resistant (MDR) secondary infections
Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian has now taken on the role of Chief Operating Officer (COO).
Following the licensing of liquid biopsy technology owned by the University Medical Center Utrecht (UMC Utrecht), Cyclomics and the UMC Utrecht have entered into a long-standing collaboration to strengthen the synergy between both parties f
Every year LifeSciences@Work organises two Venture Challenges for startups that want to develop their idea into a solid business case. On 11 April, the spring edition of the Venture Challenge 2018 kicked off with the first three-day boot camp in Nunspeet.